Your browser doesn't support javascript.
loading
Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
Rosenthal, Sun Hee; Gerasimova, Anna; Ma, Charles; Li, Hai-Rong; Grupe, Andrew; Chong, Hansook; Acab, Allan; Smolgovsky, Alla; Owen, Renius; Elzinga, Christopher; Chen, Rebecca; Sugganth, Daniel; Freitas, Tracey; Graham, Jennifer; Champion, Kristen; Bhattacharya, Anindya; Racke, Frederick; Lacbawan, Felicitas.
Afiliação
  • Rosenthal SH; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Gerasimova A; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Ma C; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Li HR; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Grupe A; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Chong H; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Acab A; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Smolgovsky A; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Owen R; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Elzinga C; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Chen R; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Sugganth D; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Freitas T; Department of Molecular Oncology, Med Fusion, Lewisville, TX, United States of America.
  • Graham J; Department of Molecular Oncology, Med Fusion, Lewisville, TX, United States of America.
  • Champion K; Department of Molecular Oncology, Med Fusion, Lewisville, TX, United States of America.
  • Bhattacharya A; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Racke F; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
  • Lacbawan F; Department of Advanced Diagnostics, Quest Diagnostics, San Juan Capistrano, CA, United States of America.
PLoS One ; 16(4): e0243683, 2021.
Article em En | MEDLINE | ID: mdl-33909614
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Neoplasias Hematológicas / Sequenciamento de Nucleotídeos em Larga Escala / Mutação / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: PLoS One Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Neoplasias Hematológicas / Sequenciamento de Nucleotídeos em Larga Escala / Mutação / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: PLoS One Ano de publicação: 2021 Tipo de documento: Article